Literature DB >> 10644068

Ionized prodrugs of dehydroepiandrosterone for transdermal iontophoretic delivery.

S Laneri1, A Sacchi, E A di Frassello, E Luraschi, P Colombo, P Santi.   

Abstract

PURPOSE: The aim of this work was to synthesize ionized dehydroepiandrosterone (DHEA) prodrugs with higher water solubility, useful for iontophoretic transdermal application.
METHODS: The synthesized derivatives were characterized and tested for sensitivity to chemical and enzymatic hydrolysis. Solid state and solution stability was also determined. Transdermal iontophoretic anodal transport in vitro was studied using excised rabbit skin.
RESULTS: Two DHEA ionized prodrugs were synthesized: PRO1, a primary amine derivative, and PRO2, a quaternary ammonium salt. The two derivatives possess higher water solubility and lower octanol/saline partition coefficients than DHEA. Prodrugs were sensitive to enzymatic hydrolysis; in particular the primary amine was hydrolyzed faster than the quaternary salt by esterase from porcine liver in vitro. Transdermal flux of the two prodrugs was slightly higher than the parent drug. In the case of passive diffusion, only DHEA was found in the receptor compartment, indicating the complete breakdown of the prodrug in the skin. Current application gave higher drug flux and a significant amount of prodrug was found in the receptor.
CONCLUSIONS: The use of ionized prodrugs of DHEA can increase the flux attainable during transdermal anodal iontophoresis by up to 7 times, but they are useful for passive transport as well.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10644068     DOI: 10.1023/a:1018991023618

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  11 in total

Review 1.  Dehydroepiandrosterone and diseases of aging.

Authors:  R R Watson; A Huls; M Araghinikuam; S Chung
Journal:  Drugs Aging       Date:  1996-10       Impact factor: 3.923

2.  Convective solvent flow across the skin during iontophoresis.

Authors:  A Kim; P G Green; G Rao; R H Guy
Journal:  Pharm Res       Date:  1993-09       Impact factor: 4.200

3.  Dehydroepiandrosterone (DHEA) treatment of depression.

Authors:  O M Wolkowitz; V I Reus; E Roberts; F Manfredi; T Chan; W J Raum; S Ormiston; R Johnson; J Canick; L Brizendine; H Weingartner
Journal:  Biol Psychiatry       Date:  1997-02-01       Impact factor: 13.382

Review 4.  Dehydroepiandrosterone, dehydroepiandrosterone sulphate and cardiovascular disease.

Authors:  K T Khaw
Journal:  J Endocrinol       Date:  1996-09       Impact factor: 4.286

5.  Iontophoretic delivery of a series of tripeptides across the skin in vitro.

Authors:  P G Green; R S Hinz; A Kim; F C Szoka; R H Guy
Journal:  Pharm Res       Date:  1991-09       Impact factor: 4.200

6.  Dodecyl N,N-dimethylamino acetate and azone enhance drug penetration across human, snake, and rabbit skin.

Authors:  J Hirvonen; J H Rytting; P Paronen; A Urtti
Journal:  Pharm Res       Date:  1991-07       Impact factor: 4.200

7.  Inhibition of HIV-1 latency reactivation by dehydroepiandrosterone (DHEA) and an analog of DHEA.

Authors:  J Y Yang; A Schwartz; E E Henderson
Journal:  AIDS Res Hum Retroviruses       Date:  1993-08       Impact factor: 2.205

8.  Characterization of esterase and alcohol dehydrogenase activity in skin. Metabolism of retinyl palmitate to retinol (vitamin A) during percutaneous absorption.

Authors:  J Boehnlein; A Sakr; J L Lichtin; R L Bronaugh
Journal:  Pharm Res       Date:  1994-08       Impact factor: 4.200

9.  Postmenopausal steroid replacement with micronized dehydroepiandrosterone: preliminary oral bioavailability and dose proportionality studies.

Authors:  J E Buster; P R Casson; A B Straughn; D Dale; E S Umstot; N Chiamori; G E Abraham
Journal:  Am J Obstet Gynecol       Date:  1992-04       Impact factor: 8.661

10.  Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age.

Authors:  A J Morales; J J Nolan; J C Nelson; S S Yen
Journal:  J Clin Endocrinol Metab       Date:  1994-06       Impact factor: 5.958

View more
  2 in total

1.  Iontophoresis-facilitated delivery of prednisolone through throat skin to the trachea after topical application of its succinate salt.

Authors:  Hiroshi Ishii; Tsukasa Suzuki; Hiroaki Todo; Mitsuhiro Kamimura; Kenji Sugibayashi
Journal:  Pharm Res       Date:  2010-12-23       Impact factor: 4.200

2.  Topical iontophoresis of valaciclovir hydrochloride improves cutaneous aciclovir delivery.

Authors:  Nada Abla; Aarti Naik; Richard H Guy; Yogeshvar N Kalia
Journal:  Pharm Res       Date:  2006-08       Impact factor: 4.200

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.